Marc Maillard

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


135 publications

2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1996 | 1993 | 1989 | 1988 | 1987 |
 
Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers.
Schantl A.E., Verhulst A., Neven E., Behets G.J., D'Haese P.C., Maillard M., Mordasini D., Phan O., Burnier M., Spaggiari D. et al., 2020/02/05. Nature communications, 11 (1) p. 721. Peer-reviewed.
 
Time-course of sodium transport along the nephron in nephrotic syndrome: The role of potassium.
Dizin E., Olivier V., Maire C., Komarynets O., Sassi A., Roth I., Loffing J., de Seigneux S., Maillard M., Rutkowski J.M. et al., 2020/02. FASEB journal, 34 (2) pp. 2408-2424. Peer-reviewed.
 
Short-term changes in dietary sodium intake influence sweat sodium concentration and muscle sodium content in healthy individuals.
Braconnier P., Milani B., Loncle N., Lourenco J.M., Brito W., Delacoste J., Maillard M., Stuber M., Burnier M., Pruijm M., 2020/01. Journal of hypertension, 38 (1) pp. 159-166. Peer-reviewed.
 
The intrinsic circadian clock in podocytes controls glomerular filtration rate.
Ansermet C., Centeno G., Nikolaeva S., Maillard M.P., Pradervand S., Firsov D., 2019/11/06. Scientific reports, 9 (1) p. 16089. Peer-reviewed.
 
Sex and Body Mass Index Modify the Association Between Leptin and Sodium Excretion: A Cross-sectional Study in an African Population.
Schwotzer N., Burnier M., Maillard M., Bovet P., Paccaud F., Bochud M., Wuerzner G., 2019/10/16. American journal of hypertension, 32 (11) pp. 1101-1108. Peer-reviewed.
 
Lack of Renal Tubular Glucocorticoid Receptor Decreases the Thiazide-Sensitive Na<sup>+</sup>/Cl<sup>-</sup> Cotransporter NCC and Transiently Affects Sodium Handling.
Canonica J., Frateschi S., Boscardin E., Ebering A., Sergi C., Jäger Y., Peyrollaz T., Mérillat A.M., Maillard M., Klusonova P. et al., 2019. Frontiers in physiology, 10 p. 989. Peer-reviewed.
 
Plasma Potassium Determines NCC Abundance in Adult Kidney-Specific γENaC Knockout.
Boscardin E., Perrier R., Sergi C., Maillard M.P., Loffing J., Loffing-Cueni D., Koesters R., Rossier B.C., Hummler E., 2018/03. Journal of the American Society of Nephrology, 29 (3) pp. 977-990. Peer-reviewed.
 
Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
Hullin R., Métrich M., Sarre A., Basquin D., Maillard M., Regamey J., Martin D., 2018/02/01. Cardiovascular research, 114 (2) pp. 272-281. Peer-reviewed.
Blood Pressure and Renal Responses to Orthostatic Stress Before and After Radiofrequency Renal Denervation in Patients with Resistant Hypertension.
Vuignier Y., Grouzmann E., Muller O., Vakilzadeh N., Faouzi M., Maillard M.P., Qanadli S.D., Burnier M., Wuerzner G., 2018. Frontiers in cardiovascular medicine, 5 p. 42. Peer-reviewed.
Dietary sodium induces a redistribution of the tubular metabolic workload.
Udwan K., Abed A., Roth I., Dizin E., Maillard M., Bettoni C., Loffing J., Wagner C.A., Edwards A., Feraille E., 2017/11/15. The Journal of physiology, 595 (22) pp. 6905-6922. Peer-reviewed.
Severe hyperkalemia is rescued by low-potassium diet in renal βENaC-deficient mice.
Boscardin E., Perrier R., Sergi C., Maillard M., Loffing J., Loffing-Cueni D., Koesters R., Rossier B.C., Hummler E., 2017/10. Pflugers Archiv, 469 (10) pp. 1387-1399. Peer-reviewed.
 
Renal Tubular Ubiquitin-Protein Ligase NEDD4-2 Is Required for Renal Adaptation during Long-Term Potassium Depletion.
Al-Qusairi L., Basquin D., Roy A., Rajaram R.D., Maillard M.P., Subramanya A.R., Staub O., 2017/08. Journal of the American Society of Nephrology, 28 (8) pp. 2431-2442. Peer-reviewed.
Nephron-Specific Deletion of Circadian Clock Gene Bmal1 Alters the Plasma and Renal Metabolome and Impairs Drug Disposition.
Nikolaeva S., Ansermet C., Centeno G., Pradervand S., Bize V., Mordasini D., Henry H., Koesters R., Maillard M., Bonny O. et al., 2016/10. Journal of the American Society of Nephrology : JASN, 27 (10) pp. 2997-3004. Peer-reviewed.
Renal tubular SGK1 deficiency causes impaired K+ excretion via loss of regulation of NEDD4-2/WNK1 and ENaC.
Al-Qusairi L., Basquin D., Roy A., Stifanelli M., Rajaram R.D., Debonneville A., Nita I., Maillard M., Loffing J., Subramanya A.R. et al., 2016/08/01. American journal of physiology. Renal physiology, 311 (2) pp. F330-42. Peer-reviewed.
Severe Salt-Losing Syndrome and Hyperkalemia Induced by Adult Nephron-Specific Knockout of the Epithelial Sodium Channel α-Subunit.
Perrier R., Boscardin E., Malsure S., Sergi C., Maillard M.P., Loffing J., Loffing-Cueni D., Sørensen M.V., Koesters R., Rossier B.C. et al., 2016/08. Journal of the American Society of Nephrology, 27 (8) pp. 2309-2318. Peer-reviewed.
Adult nephron-specific MR-deficient mice develop a severe renal PHA-1 phenotype.
Canonica J., Sergi C., Maillard M., Klusonova P., Odermatt A., Koesters R., Loffing-Cueni D., Loffing J., Rossier B., Frateschi S. et al., 2016/05. Pflugers Archiv : European journal of physiology, 468 (5) pp. 895-908. Peer-reviewed.
Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
Muller M.E., Forni Ogna V., Maillard M., Stoudmann C., Zweiacker C., Anex C., Wuerzner G., Burnier M., Bonny O., 2015/12. Pflugers Archiv, 467 (12) pp. 2413-2421. Peer-reviewed.
 
9C.09: TREATMENT WITH CANDESARTAN UNMASKS HIGHER URINARY NOREPINEPHRINE EXCRETION IN WHITE COAT HYPERTENSIVE PATIENTS COMPARED TO HEALTHY NORMOTENSIVE PARTICIPANTS.
Vakilzadeh N., Grouzmann E., Maillard M., Burnier M., Wuerzner G., 2015/06. pp. e125 dans Journal of Hypertension V. Peer-reviewed.
 
Comparative Effect of a Renin Inhibitor and a Thiazide Diuretic on Renal Tissue Oxygenation in Hypertensive Patients.
Vakilzadeh N., Muller M.E., Forni V., Milani B., Hoffman L., Piskunowicz M., Maillard M., Zweiacker C., Pruijm M., Burnier M., 2015. Kidney and Blood Pressure Research, 40 (5) pp. 542-554. Peer-reviewed.
Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
Phan O., Maillard M., Malluche H.H., Stehle J.C., Funk F., Burnier M., 2015. Biomed Research International, 2015 p. 515606. Peer-reviewed.
ENaC activity in collecting ducts modulates NCC in cirrhotic mice.
Mordasini D., Loffing-Cueni D., Loffing J., Beatrice R., Maillard M.P., Hummler E., Burnier M., Escher G., Vogt B., 2015. Pflügers Archiv : European Journal of Physiology, 467 (12) pp. 2529-2539. Peer-reviewed.
Epithelial Sodium Channel-Mediated Sodium Transport Is Not Dependent on the Membrane-Bound Serine Protease CAP2/Tmprss4.
Keppner A., Andreasen D., Mérillat A.M., Bapst J., Ansermet C., Wang Q., Maillard M., Malsure S., Nobile A., Hummler E., 2015. Plos One, 10 (8) pp. e0135224. Peer-reviewed.
 
Colon-specific deletion of epithelial sodium channel causes sodium loss and aldosterone resistance.
Malsure S., Wang Q., Charles R.P., Sergi C., Perrier R., Christensen B.M., Maillard M., Rossier B.C., Hummler E., 2014. Journal of the American Society of Nephrology, 25 (7) pp. 1453-1464. Peer-reviewed.
Local Renal Circadian Clocks Control Fluid-Electrolyte Homeostasis and BP.
Tokonami N., Mordasini D., Pradervand S., Centeno G., Jouffe C., Maillard M., Bonny O., Gachon F., Gomez R.A., Sequeira-Lopez M.L. et al., 2014. Journal of the American Society of Nephrology, 25 (7) pp. 1430-1439.
 
Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes.
Pruijm M., Hofmann L., Zanchi A., Maillard M., Forni V., Muller M.E., Wuerzner G., Vogt B., Stuber M., Burnier M., 2013. Diabetes Research and Clinical Practice, 99 (2) pp. 136-144. Peer-reviewed.
 
Effect of dark chocolate on renal tissue oxygenation as measured by BOLD-MRI in healthy volunteers.
Pruijm M., Hofmann L., Charollais-Thoenig J., Forni V., Maillard M., Coristine A., Stuber M., Burnier M., Vogt B., 2013. Clinical Nephrology, 80 (9) pp. 211-217.
Mice carrying ubiquitin-specific protease 2 (Usp2) gene inactivation maintain normal sodium balance and blood pressure.
Pouly D., Debonneville A., Ruffieux-Daidié D., Maillard M., Abriel H., Loffing J., Staub O., 2013. American Journal of Physiology. Renal Physiology, 305 (1) pp. F21-F30. Peer-reviewed.
 
PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats.
Phan O., Maillard M., Peregaux C., Mordasini D., Stehle J.C., Funk F., Burnier M., 2013. Journal of Pharmacology and Experimental Therapeutics, 346 (2) pp. 281-289.
 
Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent hypertension.
Ronzaud C., Loffing-Cueni D., Hausel P., Debonneville A., Malsure S.R., Fowler-Jaeger N., Boase N.A., Perrier R., Maillard M., Yang B. et al., 2013. Journal of Clinical Investigation, 123 (2) pp. 657-665.
Estimation of glomerular filtration rate in hospitalised patients: are we overestimating renal function?
Frank M., Guarino-Gubler S., Burnier M., Maillard M., Keller F., Gabutti L., 2012/12/19. Swiss medical weekly, 142 pp. w13708. Peer-reviewed.
 
Hypertoniebehandlung bei Nierenarterienstenose [Hypertension therapy in patients with renal artery stenosis].
Vogt B., Maillard M., Burnier M., 2012/05. Therapeutische Umschau. Revue Thérapeutique, 69 (5) pp. 279-281.
 
Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension.
Guessous I., Dobrinas M., Kutalik Z., Pruijm M., Ehret G., Maillard M., Bergmann S., Beckmann J.S., Cusi D., Rizzi F. et al., 2012. Human Molecular Genetics, 21 (14) pp. 3283-3292. Peer-reviewed.
 
Impact of salt on cardiac differential gene expression and coronary lesion in normotensive mineralocorticoid-treated mice.
Wang Q., Domenighetti A.A., Schäfer S.C., Weber J., Simon A., Maillard M.P., Pedrazzini T., Chen J., Lehr H.A., Burnier M., 2012. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 302 (9) pp. R1025-R1033.
 
Inducible kidney-specific Sgk1 knockout mice show a salt-losing phenotype.
Faresse N., Lagnaz D., Debonneville A., Ismailji A., Maillard M., Fejes-Toth G., Náray-Fejes-Tóth A., Staub O., 2012. American Journal of Physiology. Renal Physiology, 302 (8) pp. F977-F985.
Renal perfusion evaluation with contrast-enhanced ultrasonography.
Schneider A.G., Hofmann L., Wuerzner G., Glatz N., Maillard M., Meuwly J.Y., Eggimann P., Burnier M., Vogt B., 2012. Nephrology, Dialysis, Transplantation, 27 (2) pp. 674-681. Peer-reviewed.
 
Short-term increase in particulate matter blunts nocturnal blood pressure dipping and daytime urinary sodium excretion
Tsai Dai-Hua, Riediker Michael, Wuerzner Grégoire, Maillard Marc, Marques-Vidal Pedro, Paccaud Fred, Vollenweider Peter, Burnier Michel, Bochud Murielle, 2012. Hypertension, 60 (4) pp. 1061-1069. Peer-reviewed.
The circadian clock modulates renal sodium handling.
Nikolaeva S., Pradervand S., Centeno G., Zavadova V., Tokonami N., Maillard M., Bonny O., Firsov D., 2012. Journal of the American Society of Nephrology, 23 (6) pp. 1019-1026. Peer-reviewed.
The glucocorticoid-induced leucine zipper (gilz/tsc22d3-2) gene locus plays a crucial role in male fertility.
Suarez P.E., Rodriguez E.G., Soundararajan R., Mérillat A.M., Stehle J.C., Rotman S., Roger T., Voirol M.J., Wang J., Gross O. et al., 2012. Molecular Endocrinology, 26 (6) pp. 1000-1013.
 
Circadian rythm of renal urate handling in the general population.
Bochud Murielle, Maillard Marc P., Lyngdoh Tanica, Vollenweider Peter, Paccaud Fred, Burnier Michel, 2011. pp. e111 dans 21st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
 
Combining blockers of the renin-angiotensin system or increasing the dose of an angiotensin II receptor antagonist in proteinuric patients: a randomized triple-crossover study.
Meier P., Maillard M.P., Meier J.R., Tremblay S., Gauthier T., Burnier M., 2011. Journal of Hypertension, 29 (6) pp. 1228-1235.
 
Increased daytime proximal sodium reabsorption is associated with reduced nocturnal blood pressure dipping in the general population.
Bochud Murielle, Wuezner Grégoire, Maillard Marc, Beggah Ahmed, Vollenweider Peter, Paccaud Fred, Burnier Michel, 2011. pp. e6-e7 dans 21st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
 
Obesity is associated with increased daytime and night-time proximal tubular sodium reabsorption in the general adult population.
Bochud Murielle, Wuerzner Grégoire, Maillard Marc, Vollenweider Peter, Paccaud Fred, Burnier Michel, 2011. pp. e6 dans 21st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
Cardiac hypertrophy, low blood pressure, and low aldosterone levels in mice devoid of the three circadian PAR bZip transcription factors DBP, HLF, and TEF.
Wang Q., Maillard M., Schibler U., Burnier M., Gachon F., 2010. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 299 (4) pp. R1013-R1019. Peer-reviewed.
 
Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.
Coltamai Lionel, Maillard Marc, Simon Alexandra, Vogt Bruno, Burnier Michel, 2010. Journal of Hypertension, 28 (3) pp. 520-526.
 
Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men.
Pruijm M., Hofmann L., Maillard M., Tremblay S., Glatz N., Wuerzner G., Burnier M., Vogt B., 2010. Hypertension, 55 (5) pp. 1116-1122.
Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals.
Zanchi A., Maillard M., Jornayvaz F.R., Vinciguerra M., Deleaval P., Nussberger J., Burnier M., Pechere-Bertschi A., 2010. Diabetologia, 53 (8) pp. 1568-1575.
Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.
Padmanabhan Sandosh, Melander Olle, Johnson Toby, Di Blasio Anna Maria, Lee Wai K., Gentilini Davide, Hastie Claire E., Menni Cristina, Monti Maria Cristina, Delles Christian et al., 2010. Plos Genetics, 6 (10) pp. e1001177. Peer-reviewed.
Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region.
Pruijm M., Wuerzner G., Maillard M., Bovet P., Renaud C., Bochud M., Burnier M., 2010. Nephrology, Dialysis, Transplantation, 25 (7) pp. 2225-2231. Peer-reviewed.
 
Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.
Wuerzner G., Pruijm M., Maillard M., Bovet P., Renaud C., Burnier M., Bochud M., 2010. American Journal of Kidney Diseases, 56 (2) pp. 303-312.
 
Prevalences of masked and white-coat hypertension in the Lausanne population: the Hercules Study
Bochud Murielle, Vollenweider Peter, Maillard Marc, Barreau Yolande, Paccaud Fred, Burnier Michel, 2010. pp. e5 dans 20th Annual Meeting of the European Society of Hypertension, Journal of Hypertension. Peer-reviewed.
Sodium and potassium balance depends on αENaC expression in connecting tubule.
Christensen B.M., Perrier R., Wang Q., Zuber A.M., Maillard M., Mordasini D., Malsure S., Ronzaud C., Stehle J.C., Rossier B.C. et al., 2010. Journal of the American Society of Nephrology : Jasn, 21 (11) pp. 1942-1951. Peer-reviewed.
 
Toll-Interacting Protein Deficiency Leads to Increased Susceptibility to Acute and Chronic Colitis.
Maillard M., Bernasconil E., Holm U., Python C., Bachmann D., Bouzourene H., Burns K., Micheal P., Velinl D., 2010. pp. 7S dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society for Visceral, Surgery Swiss Association for the Study of the Liver, Swiss Association of Clinical Nutrition, Swiss Medical Weekly. Peer-reviewed.
 
Association between white-coat effect and blunted dipping of nocturnal blood pressure.
Bochud M., Bovet P., Vollenweider P., Maillard M., Paccaud F., Wandeler G., Gabriel A., Burnier M., 2009/10. American journal of hypertension, 22 (10) pp. 1054-1061. Peer-reviewed.
 
Conditional gene targeting of the ENaC subunit genes Scnn1b and Scnn1g.
Mérillat A.M., Charles R.P., Porret A., Maillard M., Rossier B., Beermann F., Hummler E., 2009/02. American Journal of Physiology. Renal physiology, 296 (2) pp. F249-F256. Peer-reviewed.
 
Calcium-sensing receptors modulate renin release in vivo and in vitro in the rat.
Maillard M.P., Tedjani A., Perregaux C., Burnier M., 2009. Journal of Hypertension, 27 (10) pp. 1980-1987.
 
Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects.
Smolander J., Vogt B., Maillard M., Zweiacker C., Littke T., Hengelage T., Burnier M., 2009. Clinical Pharmacology and Therapeutics, 85 (6) pp. 628-634.
 
Effect of Sodium Loading/Depletion on Renal Oxygenation in Young Normo-and Hypertensive Men Measured with BOLD-MRI
Pruijm M., Hofmann L., Maillard M., Tremblay S., Burnier M., Vogt B., 2009. pp. E69-E69 dans 63rd High Blood Pressure Research Conference, Hypertension. Peer-reviewed.
Ethnic differences in proximal and distal tubular sodium reabsorption are heritable in black and white populations.
Bochud M., Staessen J.A., Maillard M., Mazeko M.J., Kuznetsova T., Woodiwiss A., Richart T., Norton G., Thijs L., Elston R. et al., 2009. Journal of Hypertension, 27 (3) pp. 606-612. Peer-reviewed.
Glomerular hyperfiltration and increased proximal sodium reabsorption in type 2 diabetes in a middle-income country in the African region
Pruijm Menno T., Würzner Grégoire, Maillard Marc P., Bovet Pascal, Renaud C., Bochud Murielle, Burnier Michel, 2009. pp. S29 dans Abstract book, 19th European Meeting on Hypertension, Milan, June 12-16, 2009.
 
Independent relations of left ventricular structure with the 24-h urinary excretion of sodium and aldosterone
Yu Jin, Kuznetsova Tatiana, Maillard Marc, Richart Tom, Thijs Lutgarde, Bochud Murielle, Herregods Marie-Christine, Burnier Michel, Fagard Robert, Staessen Jan A., 2009. p. 82 dans 15th European Meeting on Hypertension, International Journal of Cardiology. Peer-reviewed.
 
Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone.
Jin Y., Kuznetsova T., Maillard M.P., Richart T., Thijs L., Bochud M., Herregods M.C., Burnier M., Fagard R., Staessen J.A., 2009. Hypertension, 54 (3) pp. 489-495. Peer-reviewed.
 
Is it appropriate to index glomerular filtration rate for body surface area
Wuerzner G., Pruijm Menno, Maillard Marc, Bovet Pascal, Renaud Claude, Bochud Murielle, Burnier Michel, 2009. pp. 4S-5S dans Annual meeting of the Swiss Society of Nephrology, Interlaken (Switzerland), December 2-4, 2009, Swiss Medical Weekly. Peer-reviewed.
 
Left ventricular structure in relation to aldosterone and renal segmeental sodium handling
Jin Yu, Kuznetsova Tatiana, Maillard Marc, Richart Tom, Thijs Lutgarde, Bochud Murielle, Herregods Marie-Christine, Burnier Michel, Fagard Robert, Staessen Jan A, 2009. Acta Clinica Belgica, 64 (2) pp. 165-166. Peer-reviewed.
Left ventricular structure in relation to aldosterone and renal segmental sodium handling
Jin Yu, Kuznetsova Tatiana, Maillard Marc P., Richart Tom, Thijs Lutgarde, Bochud Murielle, Herregods Marie-Christine, Burnier Michel, Fagard Robert, Staessen Jan A., 2009. pp. S317 dans Abstract book, 19th European Meeting on Hypertension, Milan, June 12-16, 2009.
The white coat effect is associated with reduced fall in nocturnal blood pressure
Bochud Murielle, Barreau Yolande, Maillard Marc P., Vollenweider Peter, Paccaud Fred, Burnier Michel, 2009. pp. S5 dans Abstract book, 19th European Meeting on Hypertension, Milan, June 12-16, 2009.
 
Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist.
Coltamai L., Bucher M., Maillard M.P., Shukla U., Bohidar N., Haskell L., Bertelsen K., Fedgchin M., Vogt B., Burnier M., 2009. Clinical Pharmacology and Therapeutics, 85 (2) pp. 145-148. Peer-reviewed.
Association of ABCB1 genetic variants with renal function in Africans and in Caucasians.
Bochud M., Eap C.B., Maillard M., Johnson T., Vollenweider P., Bovet P., Elston R.C., Bergmann S., Beckmann J.S., Waterworth D.M. et al., 2008. BMC Medical Genomics, 1 (21) pp. 1-11. Peer-reviewed.
 
Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4
Staessen J. A., Kuznetsova T., Zhang H., Maillard M., Bochud M., Hasenkamp S., Westerkamp J., Richart T., Thijs L., Li X. et al., 2008. Hypertension, 51 (6) pp. 1643-1650. Peer-reviewed.
 
Drug-induced alterations of sodium excretion: the example of non-steroidal anti-inflammatory agents
Maillard M, Burnier M, 2008. dans Burnier M (eds.) Sodium in Health and Disease, Marcel Dekker, New York.
 
Low adiponectin is associated with increased ambulatory pulse pressure and activation of the renin-angiotensin system in subjects of African descent
Reyna-Carmona Laura-Elena, Bochud Murielle, Maillard Marc P., Bovet Pascal, Nussberger Jürg, Burnier Michel, Teta Daniel, 2008. pp. 10S dans 40th Annual Meeting Swiss Society of Nephrology, St. Gallen, December 3-5, 2008, Swiss Medical Weekly. Peer-reviewed.
 
Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in african subjects
Bankir Lise, Bochud Murielle, Maillard Marc, Bovet Pascal, Gabriel Anne, Burnier Michel, 2008. Hypertension, 51 (4) pp. 891-898. Peer-reviewed.
Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine.
Pruijm M.T., Maillard M.P., Burnier M., 2008. Vascular Health and Risk Management, 4 (6) pp. 1159-1166.
 
Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension.
Manunta P., Maillard M., Tantardini C., Simonini M., Lanzani C., Citterio L., Stella P., Casamassima N., Burnier M., Hamlyn J.M. et al., 2008. Journal of Hypertension, 26 (5) pp. 914-920. Peer-reviewed.
 
Segmental renal sodium handling in relation to the human SAH gene.
Jin Y., Kuznetsova T., Tikhonoff V., Maillard M., Bochud M., Burnier M., Hasenkamp S., Brand E., Brand-Herrmann S.M., Richart T. et al., 2008. Hypertension, 52 (2) pp. e12-3. Peer-reviewed.
 
The leptin/adiponectin ratio: potential implications for peritoneal dialysis.
Teta D., Maillard M., Halabi G., Burnier M., 2008. Kidney International., 108 (Supplement) pp. S112-S118.
 
Renal sodium handling in patients with normal pressure glaucoma.
Pechere-Bertschi A., Sunaric-Megevand G., Haefliger I., Panarello F., Maillard M., Burnier M., 2007/06. Clinical Science, 112 (6) pp. 337-344. Peer-reviewed.
The effect of pH-neutral peritoneal dialysis fluids on adipokine secretion from cultured adipocytes
Teta D., Maillard M., Tedjani A., Passlick-Deetjen J., Burnier M., 2007/03. Nephrology, Dialysis, Transplantation, 22 (3) pp. 862-9.
 
Context dependency of serum and urinary lithium: implications for measurement of proximal sodium reabsorption.
Bochud M., Staessen J.A., Woodiwiss A., Norton G., Maillard M., Burnier M., 2007. Hypertension, 49 (5) pp. e34. Peer-reviewed.
 
CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt.
Eap C.B., Bochud M., Elston R.C., Bovet P., Maillard M.P., Nussberger J., Schild L., Shamlaye C., Burnier M., 2007. Hypertension, 49 (5) pp. 1007-14. Peer-reviewed.
Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
Maillard M.P., Burnier M., 2007. Vascular Health and Risk Management, 3 (3) pp. 265-278.
 
Renal sodium handling and nighttime blood pressure.
Burnier M., Coltamai L., Maillard M., Bochud M., 2007. Seminars in nephrology, 27 (5) pp. 565-71. Peer-reviewed.
 
Association between arterial properties and renal sodium handling in a general population
Seidlerova J., Staessen J. A., Maillard M., Nawrot T., Zhang H., Bochud M., Kuznetsova T., Richart T., Van Bortel L. M., Struijker-Boudier H. A. et al., 2006/10. Hypertension, 48 (4) pp. 609-15. Peer-reviewed.
 
Proximal tubular function and salt sensitivity.
Burnier M., Bochud M., Maillard M., 2006/04. Current Hypertension Reports, 8 (1) pp. 8-15. Peer-reviewed.
 
Association of CYP3A5 genotypes with blood pressure and renal function in African families.
Bochud M., Eap C.B., Elston R.C., Bovet P., Maillard M., Schild L., Shamlaye C., Burnier M., 2006. Journal of hypertension, 24 (5) pp. 923-9. Peer-reviewed.
 
Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs
Maillard M., Burnier M., 2006/01. Expert Opinion on Drug Safety, 5 (1) pp. 83-94.
 
Plasma aldosterone is independently associated with the metabolic syndrome.
Bochud M., Nussberger J., Bovet P., Maillard M.R., Elston R.C., Paccaud F., Shamlaye C., Burnier M., 2006. Hypertension, 48 (2) pp. 239-45. Peer-reviewed.
 
The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
Zanchi A., Perregaux C., Maillard M., Cefai D., Nussberger J., Burnier M., 2006. American journal of physiology. Endocrinology and metabolism, 291 (6) pp. E1228-34. Peer-reviewed.
 
Telmisartan/hydrochlorothiazide: a new fixed dose combination
Maillard M., Burnier M., 2005/05. Expert Review of Cardiovascular Therapy, 3 (3) pp. 375-86.
 
The future of angiotensin II inhibition in cardiovascular medicine.
Meier P., Maillard M., Burnier M., 2005/02. Current Drug Targets. Cardiovascular and Haematological Disorders, 5 (1) pp. 15-30.
 
Association between the CYP3A5 A698G polymorphism and blood pressure in individuals of east African descent
Eap Chin-Bin, Bochud Murielle, Elston Robert C., Bovet Pascal, Maillard Marc P., Burnier Michel, 2005. pp. MCV-042, p. 145 dans , CHUV Research Day.
 
Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean).
Bochud M., Elston R.C., Maillard M., Bovet P., Schild L., Shamlaye C., Burnier M., 2005. Kidney international, 67 (1) pp. 61-9. Peer-reviewed.
 
High heritability of ambulatory blood pressure in families of East African descent.
Bochud M., Bovet P., Elston R.C., Paccaud F., Falconnet C., Maillard M., Shamlaye C., Burnier M., 2005. Hypertension, 45 (3) pp. 445-450. Peer-reviewed.
 
Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men.
Wuerzner G., Chiolero A., Maillard M., Nussberger J., Burnier M., 2005. Kidney International, 68 (2) pp. 688-694. Peer-reviewed.
 
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Hasler C., Nussberger J., Maillard M., Forclaz A., Brunner H.R., Burnier M., 2005. Clinical pharmacology and therapeutics, 78 (5) pp. 501-7. Peer-reviewed.
 
The CYP3A5 polymorphism is associated with ambulatory blood pressure increase with age in families of African descent
Bochud Murielle, Eap Chin-Bin, Elston Robert C., Bovet Pascal, Schild Laurent, Maillard Marc P., Burnier Michel, 2005. p. 367 dans , Journal of Hypertension. Peer-reviewed.
 
The CYP3A5 polymorphism is associated with urinary sodium excretion in families of African descent
Bochud Murielle, Elston Robert C., Bovet Pascal, Schild Laurent, Maillard Marc P., Burnier Michel, Eap Chin-Bin, 2005. p. 364 dans , Journal of Hypertension. Peer-reviewed.
 
Effet d'un exces de poids sur les variations nycthemerales de la pression arterielle, de la fonction renale et de l'excretion sodee chez des patients hypertendus. [Influence of moderate body weight excess on the nycthemeral pattern of blood pressure, renal function and sodium and water excretion in patients with essential hypertension]
Bankir L., Sellin F., Maillard M., Chiolero A., Burnier M., 2004/08. Archives des Maladies du Coeur et des Vaisseaux, 97 (7-8) pp. 777-81.
 
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Wuerzner G., Chioléro A., Maillard M., Nussberger J., Brunner H.R., Burnier M., Chiclero A., 2004. Kidney International, 65 (1) pp. 238-244. Peer-reviewed.
 
Clinical pharmacology of angiotensin II receptor antagonists
Maillard M, Burnier M, 2004. pp. 453-484 dans Unger T, Schölkens BA (eds.) Handbook of experimental pharmacology, Springer Verlag Berlin.
 
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men.
Zanchi A., Chiolero A., Maillard M., Nussberger J., Brunner H.R., Burnier M., 2004. Journal of Clinical Endocrinology and Metabolism, 89 (3) pp. 1140-1145. Peer-reviewed.
 
Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent.
Falconnet C., Bochud M., Bovet P., Maillard M., Burnier M., 2004. Journal of hypertension, 22 (6) pp. 1213-1220. Peer-reviewed.
 
Renal hemodynamic and tubular responses to salt in women using oral contraceptives
Pechere-Bertschi A., Maillard M., Stalder H., Bischof P., Fathi M., Brunner H. R., Burnier M., 2003/10. Kidney International, 64 (4) pp. 1374-80.
 
Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?
Forclaz A., Maillard M., Nussberger J., Brunner H.R., Burnier M., 2003. Hypertension, 41 (1) pp. 31-6.
 
Recent clinical trials with omapatrilat: new developments.
Zanchi A., Maillard M., Burnier M., 2003. Current hypertension reports, 5 (4) pp. 346-52. Peer-reviewed.
 
In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist
Maillard M. P., Perregaux C., Centeno C., Stangier J., Wienen W., Brunner H. R., Burnier M., 2002/09. Journal of Pharmacology and Experimental Therapeutics, 302 (3) pp. 1089-95.
 
Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population
Vuilleumier P., Decosterd D., Maillard M., Burnier M., Hayoz D., 2002/09. Journal of Hypertension, 20 (9) pp. 1753-7.
 
Hyperuricemia, hypertension, and proteinuria associated with high-altitude polycythemia.
Jefferson J.A., Escudero E., Hurtado M.E., Kelly J.P., Swenson E.R., Wener M.H., Burnier M., Maillard M., Schreiner G.F., Schoene R.B. et al., 2002/06. American Journal of Kidney Diseases, 39 (6) pp. 1135-1142.
 
Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?
Chiolero A., Maillard M. P., Burnier M., 2002/05. Expert Opinion on Drug Safety, 1 (1) pp. 45-52.
 
Renal segmental tubular response to salt during the normal menstrual cycle
Pechere-Bertschi A., Maillard M., Stalder H., Brunner H. R., Burnier M., 2002/02. Kidney International, 61 (2) pp. 425-31.
 
Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
Maillard M.P., Würzner G., Nussberger J., Centeno C., Burnier M., Brunner H.R., 2002. Clinical pharmacology and therapeutics, 71 (1) pp. 68-76. Peer-reviewed.
 
Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
Regamey F., Maillard M., Nussberger J., Brunner H.R., Burnier M., 2002. Hypertension, 40 (3) pp. 266-72.
 
Dose protein binding modulate the effect of angiotensin II receptor antagonists
Maillard MP, Centeno C, Frostell-Karlsson A, Brunner HR, Burnier M, 2001/03. Journal of the Renin-Angiotensin-Aldosterone System, 2 (Suppl 1) pp. S54-S58.
 
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
Würzner G., Gerster J.C., Chiolero A., Maillard M., Fallab-Stubi C.L., Brunner H.R., Burnier M., 2001. Journal of Hypertension, 19 (10) pp. 1855-1860. Peer-reviewed.
 
Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous mice.
Wang Q., Hummler E., Maillard M., Nussberger J., Rossier B.C., Brunner H.R., Burnier M., 2001. Kidney international, 59 (6) pp. 2216-21. Peer-reviewed.
 
Renal and neurohormonal responses to increasing levels of lower body negative pressure in men.
Würzner G., Chiolero A., Maillard M., Nussberger J., Hayoz D., Brunner H.R., Burnier M., 2001. Kidney international, 60 (4) pp. 1469-76. Peer-reviewed.
 
The comparative pharmacology of angiotensin II receptor antagonists
Burnier M., Maillard M., 2001. Blood Pressure. Supplement, 1 pp. 6-11.
 
Blood pressure and renal haemodynamic response to salt during the normal menstrual cycle.
Pechère-Bertschi A., Maillard M., Stalder H., Brunner H.R., Burnier M., 2000/06. Clinical Science, 98 (6) pp. 697-702. Peer-reviewed.
 
Angiotensin II receptor antagonists: where do we stand?
Burnier M., Maillard M., 2000/03. IDrugs, 3 (3) pp. 304-309. Peer-reviewed.
 
Angiotensin II receptor antagonists: where do we stand?
Burnier M., Maillard M., 2000/03. IDrugs, 3 (3) pp. 304-9.
 
Salt- and angiotensin II-dependent variations in amiloride-sensitive rectal potential difference in mice
Wang Q., Horisberger J. D., Maillard M., Brunner H. R., Rossier B. C., Burnier M., 2000/02. Clinical and Experimental Pharmacology and Physiology, 27 (1-2) pp. 60-6.
 
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6.
Maillard M.P., Rossat J., Nussberger J., Ramis J., Pontes C., Burnier M., Brunner H.R., 2000. Journal of cardiovascular pharmacology, 35 (3) pp. 383-9. Peer-reviewed.
 
Proximal sodium reabsorption: An independent determinant of blood pressure response to salt.
Chiolero A., Maillard M., Nussberger J., Brunner H.R., Burnier M., 2000. Hypertension, 36 (4) pp. 631-7.
 
Renal sodium handling in acute and chronic salt loading/depletion protocols: the confounding influence of acute water loading.
Burnier M., Monod M.L., Chioléro A., Maillard M., Nussberger J., Brunner H.R., 2000. Journal of hypertension, 18 (11) pp. 1657-64. Peer-reviewed.
 
Tasosartan, enoltasosartan, and angiotensin II receptor blockade: the confounding role of protein binding.
Maillard M.P., Rossat J., Brunner H.R., Burnier M., 2000. The Journal of pharmacology and experimental therapeutics, 295 (2) pp. 649-54. Peer-reviewed.
 
Adducin polymorphism affects renal proximal tubule reabsorption in hypertension
Manunta P., Burnier M., D'Amico M., Buzzi L., Maillard M., Barlassina C., Lanella G., Cusi D., Bianchi G., 1999/02. Hypertension, 33 (2) pp. 694-7.
 
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Mazzolai L., Maillard M., Rossat J., Nussberger J., Brunner H.R., Burnier M., 1999. Hypertension, 33 (3) pp. 850-5. Peer-reviewed.
Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay.
Maillard M.P., Mazzolai L., Daven V., Centeno C., Nussberger J., Brunner H.R., Burnier M., 1999. American journal of hypertension, 12 (12 Pt 1-2) pp. 1201-8. Peer-reviewed.
 
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
Rossat J., Maillard M., Nussberger J., Brunner H.R., Burnier M., 1999. Clinical pharmacology and therapeutics, 66 (1) pp. 76-84. Peer-reviewed.
 
Cytotoxic coumarins from the aerial parts of Tordylium apulum and their effects on a non-small-cell bronchial carcinoma line
Kofinas C., Chinou I., Loukis A., Harvala C., Roussakis C., Maillard M., Hostettmann K., 1998/03. Planta Medica, 64 (2) pp. 174-6.
 
Antimicrobial steroids from the fungus Fomitopsis pinicola
Keller A. C., Maillard M. P., Hostettmann K., 1996/03. Phytochemistry, 41 (4) pp. 1041-6.
 
Search for molluscicidal and antifungal saponins from tropical plants
Hostettmann K., Marston A., Maillard M., Wolfender J. L., 1996. Advances in Experimental Medicine and Biology, 404 pp. 117-28.
 
Search for antifungal, molluscicidal and larvicidal compounds from African medicinal plants
Marston A., Maillard M., Hostettmann K., 1993/03. Journal of Ethnopharmacology, 38 (2-3) pp. 215-23.
 
An Antifungal Isoflavanone and a Structure Revision of a Flavanone from Erythrina berteroana
Maillard M., Hamburger M., Gupta M. P., Hostettmann K., 1989/06. Planta Medica, 55 (3) pp. 281-2.
 
Antifungal flavonoids from the leaf surfaces of Helichrysum nitens and from the stem bark of Erythrina berteroana
Tomas-Barberan F. A., Maillard M., Hostettmann K., 1988. Progress in Clinical and Biological Research, 280 pp. 61-5.
 
A new antifungal prenylated flavanone from Erythrina berteroana
Maillard M., Gupta M. P., Hostettmann K., 1987/12. Planta Medica, 53 (6) pp. 563-4.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University